Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.710
+0.080 (4.91%)
At close: Oct 29, 2024, 4:00 PM
1.700
-0.010 (-0.58%)
After-hours: Oct 29, 2024, 7:56 PM EDT

Akebia Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
39.542.9390.47149.8228.7147.45
Upgrade
Short-Term Investments
----39.990.25
Upgrade
Cash & Short-Term Investments
39.542.9390.47149.8268.69147.69
Upgrade
Cash Growth
-26.27%-52.55%-39.61%-44.25%81.92%-54.08%
Upgrade
Accounts Receivable
29.7739.2940.2855.8928.5838.86
Upgrade
Receivables
29.7739.2940.2855.8928.5838.86
Upgrade
Inventory
23.8715.6921.5736.6361.02116.35
Upgrade
Prepaid Expenses
11.6314.4915.6228.8312.766.36
Upgrade
Restricted Cash
----0.40.26
Upgrade
Other Current Assets
7.335.7517.25---
Upgrade
Total Current Assets
112.1118.15185.18271.15371.44309.53
Upgrade
Property, Plant & Equipment
13.2616.0534.3740.6135.539.42
Upgrade
Goodwill
59.0459.0459.0459.0455.0555.05
Upgrade
Other Intangible Assets
18.0236.0472.08108.13144.17291.21
Upgrade
Other Long-Term Assets
17.7812.425.3750.4237.9875.99
Upgrade
Total Assets
220.2241.7356.05529.35644.14771.2
Upgrade
Accounts Payable
10.1114.6418.0233.5941.3139.22
Upgrade
Accrued Expenses
27.2342.9453.9297.51125.34124.08
Upgrade
Current Portion of Long-Term Debt
2.0119.553297.54--
Upgrade
Current Portion of Leases
5.184.494.744.85.294.99
Upgrade
Current Unearned Revenue
43.3-3.7420.9115.2139.83
Upgrade
Other Current Liabilities
19.4718.2617.126.7--
Upgrade
Total Current Liabilities
107.399.87129.54261.05187.15208.12
Upgrade
Long-Term Debt
91.1371.291.5653.0896.3875.81
Upgrade
Long-Term Leases
6.38.9528.9633.724.6227.53
Upgrade
Long-Term Unearned Revenue
-43.343.321.4725.3533.12
Upgrade
Other Long-Term Liabilities
49.2248.9857.4786.0363.0331.87
Upgrade
Total Liabilities
253.95272.29350.82455.34396.52376.44
Upgrade
Common Stock
000000
Upgrade
Additional Paid-In Capital
1,6021,5781,5621,5371,4251,189
Upgrade
Retained Earnings
-1,636-1,609-1,557-1,463-1,178-794.05
Upgrade
Comprehensive Income & Other
0.010.010.010.010.01-
Upgrade
Total Common Equity
-33.75-30.585.2374.01247.62394.76
Upgrade
Shareholders' Equity
-33.75-30.585.2374.01247.62394.76
Upgrade
Total Liabilities & Equity
220.2241.7356.05529.35644.14771.2
Upgrade
Total Debt
104.62104.18157.27189.13126.29108.32
Upgrade
Net Cash (Debt)
-65.12-61.26-66.8-39.33142.4139.37
Upgrade
Net Cash Growth
----261.69%-87.16%
Upgrade
Net Cash Per Share
-0.33-0.33-0.37-0.241.030.33
Upgrade
Filing Date Shares Outstanding
210.29209.37184.25181.23153.5129.86
Upgrade
Total Common Shares Outstanding
209.93194.58184.14177148.07121.67
Upgrade
Working Capital
4.818.2855.6510.1184.29101.42
Upgrade
Book Value Per Share
-0.16-0.160.030.421.673.24
Upgrade
Tangible Book Value
-110.82-125.67-125.9-93.1648.448.49
Upgrade
Tangible Book Value Per Share
-0.53-0.65-0.68-0.530.330.40
Upgrade
Machinery
---5.855.795.55
Upgrade
Leasehold Improvements
---8.578.578.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.